Abeona Therapeutics Inc.
ABEO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000318306
In the last 90 days, Abeona Therapeutics Inc. insiders filed 0 open-market purchases and 10 sales; 126 institutions reported holding it in 13F filings for Q2 2026, worth $243.3M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Abeona Therapeutics Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 104 | 2 | 108 | +6 |
| Shares | 38.9M | 2.77M | 39.5M | +3.37M (+9.3%) |
| Value | $205.2M | $14.6M | $177.1M | −$13.4M (−7.1%) |
2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Abeona Therapeutics Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Vanguard Capital Management LLC | 2,164,851 | $9.70M | 0.00% |
| National Bank of Canada | 500,000 | $2.24M | 0.00% |
| Vanguard Fiduciary Trust Co | 339,515 | $1.52M | 0.00% |
| Vanguard Portfolio Management LLC | 270,976 | $1.21M | 0.00% |
| Marshall Wace, LLP | 216,305 | $969.0K | 0.00% |
| ExodusPoint Capital Management, LP | 122,944 | $550.8K | 0.01% |
| Headlands Technologies LLC | 63,345 | $283.8K | 0.03% |
| Bridgeway Capital Management, LLC | 50,000 | $224.0K | 0.00% |
| Harbor Capital Advisors, Inc. | 35,094 | $157.0K | 0.01% |
| Dimensional Fund Advisors LP | 34,371 | $154.0K | 0.00% |
| Vanguard Global Advisers, LLC | 18,608 | $83.4K | 0.00% |
| Stifel Financial Corp | 13,975 | $62.6K | 0.00% |
| American Century Companies Inc | 12,718 | $57.0K | 0.00% |
| Kovack Advisors, Inc. | 10,560 | $48.4K | 0.00% |
| Federation des caisses Desjardins du Quebec | 3,000 | $13.4K | 0.00% |
| Beacon Investment Advisory Services, Inc. | 240 | $1.08K | 0.00% |
| EverSource Wealth Advisors, LLC | 136 | $609 | 0.00% |
Sold out (11)
Institutions that held Abeona Therapeutics Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vivo Capital, LLC | 1,842,751 | $9.71M |
| Standard Life Aberdeen plc | 616,413 | $3.25M |
| Jain Global LLC | 366,067 | $1.93M |
| Jump Financial, LLC | 75,940 | $400.2K |
| Deerfield Management Company, L.P. (Series C) | 40,000 | $210.8K |
| Axq Capital, LP | 33,581 | $177.0K |
| Skopos Labs, Inc. | 25,779 | $138.4K |
| PVG Asset Management Corp | 12,570 | $66.2K |
| SG Americas Securities, LLC | 10,731 | $57.0K |
| Amalgamated Bank | 1,372 | $7.00K |
| Vermillion & White Wealth Management Group, LLC | 370 | $1.95K |
Not filed for Q1 2026 yet (2)
Institutions that held Abeona Therapeutics Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 2,757,143 | $14.5M |
| Sherbrooke Park Advisers LLC | 15,556 | $82.0K |